3,146 results match your criteria: "PET Centre[Affiliation]"
Eur Heart J
October 2024
Department of Cardiology, Gødstrup Hospital, Herning, Denmark.
Eur J Nucl Med Mol Imaging
October 2024
Department of Nuclear Medicine, AP-HP, European Hospital Georges-Pompidou, University of Paris-Cité, 75015, Paris, France.
Mov Disord
October 2024
Turku PET Centre, Turku University and Turku University Hospital, Turku, Finland.
Background: In Parkinson's disease (PD), postural instability and gait disorder (PIGD) symptoms are associated with a worse prognosis for an unknown reason.
Objective: The objective was to explore the relationship between cannabinoid receptor type 1 (CB1R) availability and motor symptoms in PD with [F]FMPEP-d positron emission tomography (PET).
Methods: Fifteen individuals with PD underwent [F]FMPEP-d PET to measure cerebral CB1R availability.
PET Clin
January 2025
King's College London & Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, Office Suite 6, 4th Floor Lambeth Wing, London, UK; St Thomas' Hospital, Westminster Bridge Road, London SE1 7EH, UK.
Presurgical evaluation aims to localize the seizure onset zone (SOZ) for a tailored resection. Interictal [F]fluorodeoxyglucose PET is now an established test to lateralize and/or localize the SOZ, particularly if MR imaging is negative or if the noninvasive assessment shows discrepancies. PET can show hypometabolic areas associated with SOZ and the potential altered metabolic brain networks.
View Article and Find Full Text PDFOpen Heart
October 2024
Heart Center, Kuopio University Hospital, Kuopio, Finland.
Background: Despite tremendous therapeutic advancements, a significant proportion of coronary artery disease patients suffer from refractory angina pectoris, that is, quality-of-life-compromising angina that is non-manageable with established pharmacological and interventional treatment options. Adenoviral vascular endothelial growth factor-D (AdVEGF-D)-encoding gene therapy (GT) holds promise for the treatment of refractory angina.
Methods: ReGenHeart is an investigator-initiated, multicentre, randomised, placebo-controlled and double-blinded phase 2 clinical trial that aims to study the safety and efficacy of intramyocardially administered angiogenic AdVEGF-D GT for refractory angina.
Sci Rep
October 2024
Turku PET Centre, University of Turku, Turku University Hospital, c/o TYKS, P. o. Box 52, Turku, FI 20521, Finland.
The aim of this study was to investigate whether a reduction in accelerometer-measured sedentary behavior (SB) improves blood lipids in inactive adults with metabolic syndrome (MetS). Sixty-four participants were randomly assigned into intervention (INT, n = 33) and control (CONT, n = 31) groups. The INT group was instructed to reduce SB by 1 h/day without increasing formal exercise, whereas the CONT group was advised to maintain usual SB habits.
View Article and Find Full Text PDFNucl Med Commun
January 2025
Department of Pediatric Surgery, Turku University Hospital.
Nat Commun
October 2024
Department of Biosciences, University of Oslo, Oslo, Norway.
Unfolded protein response (UPR) is a central stress response pathway that is hijacked by tumor cells for their survival. Here, we find that IRE1α signaling, one of the canonical UPR arms, is increased in prostate cancer (PCa) patient tumors. Genetic or small molecule inhibition of IRE1α in syngeneic mouse PCa models and an orthotopic model decreases tumor growth.
View Article and Find Full Text PDFIEEE Trans Radiat Plasma Med Sci
November 2024
King's College London & Guy's and St Thomas' PET Centre, King's College London.
Brain Stimul
December 2024
Turku Brain and Mind Center, Clinical Neurosciences, University of Turku, Turku, Finland; Neurocenter, Turku University Hospital, Turku, Finland; Turku PET Centre, Turku University Hospital, Turku, Finland; Department of Clinical Neurophysiology, University of Turku, Finland.
Eur J Haematol
January 2025
Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
Classic Hodgkin lymphoma (CHL) is a highly curable disease, even in advanced stages. Controversy remains over whether bone involvement negatively affects overall and progression-free survival in patients treated with intensive chemotherapy regimens. Whether cases that present with bone lesions harbor specific tumor microenvironmental features is unknown.
View Article and Find Full Text PDFAlzheimers Dement
November 2024
Department of Nuclear Medicine and PET-Centre, Aarhus University Hospital, Aarhus, Denmark.
Introduction: Microglial responses are an integral part of Alzheimer's disease (AD) pathology and are associated with amyloid beta (Aβ) deposition. This study aimed to investigate the effects of Aβ and microglial responses on global cognitive impairment.
Methods: In this longitudinal study, 28 patients with mild cognitive impairment and 11 healthy controls underwent C-PK11195 and C-Pittsburgh compound B positron emission tomography (PET), structural magnetic resonance imaging scans, and global cognitive ratings at baseline and 2-year follow-up.
EJNMMI Phys
October 2024
PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Eur Heart J Cardiovasc Imaging
October 2024
Department of Cardiology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
J Pers Soc Psychol
December 2024
Turku PET Centre, University of Turku.
Every day, humans encounter complex social situations that need to be encoded effectively to allow interaction with others. Yet, principles for organizing the perception of social features from the external world remain poorly characterized. In this large-scale study, we investigated the principles of social perception in dynamic scenes.
View Article and Find Full Text PDFJ Nucl Med
November 2024
Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
MAbs
October 2024
Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Front Nucl Med
June 2024
Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Introduction: Pediatric patients have an increased risk of radiation-induced malignancies due to their ongoing development and long remaining life span. Thus, optimization of PET protocols is an important task in pediatric nuclear medicine. Long axial field-of-view (LAFOV) PET/CT has shown a significant increase in sensitivity, which provides an ideal opportunity for reduction of injected tracer activity in the pediatric population.
View Article and Find Full Text PDFNanotechnol Sci Appl
September 2024
Department of Radiology, Institute of Green Nanotechnology, University of Missouri, Columbia, MO, 65212, USA.
Background: Recent advancements in nanomedicine and nanotechnology have expanded the scope of multifunctional nanostructures, offering innovative solutions for targeted drug delivery and diagnostic agents in oncology and nuclear medicine. Nanoparticles, particularly those derived from natural sources, hold immense potential in overcoming biological barriers to enhance therapeutic efficacy and diagnostic accuracy. Papain, a natural plant protease derived from , emerges as a promising candidate for green nanotechnology-based applications due to its diverse medicinal properties, including anticancer properties.
View Article and Find Full Text PDFBMJ Open
September 2024
Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
Objectives: Sedentary behaviour (SB) is a plausible intervention target for back pain mitigation. Therefore, this study aimed to investigate the effects of a 6-month SB reduction intervention on back pain and related disability outcomes, and paraspinal muscle (ie, erector spinae and transversospinales separately) insulin sensitivity (glucose uptake, GU) and muscle fat fraction (FF).
Methods: Sixty-four adults with overweight or obesity and metabolic syndrome were randomised into intervention (n=33) and control (n=31) groups.
Biomolecules
August 2024
Turku PET Centre, University of Turku, 20521 Turku, Finland.
Obesity and sedentarism are associated with increased liver and pancreatic fat content (LFC and PFC, respectively) as well as impaired organ metabolism. Exercise training is known to decrease organ ectopic fat but its effects on organ metabolism are unclear. Genetic background affects susceptibility to obesity and the response to training.
View Article and Find Full Text PDFJ Imaging
August 2024
Department of Renal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark.
Unlabelled: The aim was to establish combined HO PET/MRI during ex vivo normothermic machine perfusion (NMP) of isolated porcine kidneys. We examined whether changes in renal arterial blood flow (RABF) are accompanied by changes of a similar magnitude in renal blood perfusion (RBP) as well as the relation between RBP and renal parenchymal oxygenation (RPO).
Methods: Pig kidneys (n = 7) were connected to a NMP circuit.
Clin Neurophysiol
November 2024
Cognitive Brain Research Unit & Centre of Excellence in Music, Mind, Body and Brain, Department of Psychology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Objective: To determine the early development of novelty detection and the effect of familial dyslexia risk and infant music intervention on this development.
Methods: In the longitudinal DyslexiaBaby study, we investigated the maturation of novelty-P3 and late-discriminative negativity (LDN) event-related potentials to novel sounds at birth (N = 177) and at the ages of 6 (N = 83) and 28 months (N = 131).
Results: Novelty-P3 was elicited at all ages, whereas LDN was elicited at 6 and 28 months.
Indian J Radiol Imaging
October 2024
National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, Thailand.
[ Lu]Lu-prostate-specific membrane antigen (PSMA)-617 radioligand therapy (RLT) shows promise for metastatic castration-resistant prostate cancer (mCRPC) patients with positive PSMA positron emission tomography (PET) imaging. Identifying high-risk patients is crucial. We evaluated pretherapeutic PSMA PET-derived parameters to predict prostate-specific antigen (PSA) response in patients undergoing [ Lu]Lu-PSMA-617 RLT.
View Article and Find Full Text PDFBreast
December 2024
Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
Purpose: The recently released EANM/SNMMI guideline, endorsed by several important clinical and imaging societies in the field of breast cancer (BC) care (ACR, ESSO, ESTRO, EUSOBI/ESR, EUSOMA), emphasized the role of [F]FDG PET/CT in management of patients with no special type (NST) BC. This review identifies and summarizes similarities, discrepancies and novelties of the EANM/SNMMI guideline compared to NCCN, ESMO and ABC recommendations.
Methods: The EANM/SNMMI guideline was based on a systematic literature search and the AGREE tool.